Your browser doesn't support javascript.
loading
Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients.
Shahriari-Felordi, Mahtab; Alikhani, Hani Keshavarz; Hashemian, Seyed-Mohammad Reza; Hassan, Moustapha; Vosough, Massoud.
Afiliação
  • Shahriari-Felordi M; Department of Molecular Cell Biology-Genetics, Faculty of Basic Sciences and Advanced Technologies in biology, University of Science and Culture, Tehran, Iran.
  • Alikhani HK; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Hashemian SR; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Hassan M; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Vosough M; Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Mol Biol Rep ; 49(2): 1545-1549, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35028855
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator 4 Ativador da Transcrição / Estresse do Retículo Endoplasmático / COVID-19 / Chaperona BiP do Retículo Endoplasmático Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator 4 Ativador da Transcrição / Estresse do Retículo Endoplasmático / COVID-19 / Chaperona BiP do Retículo Endoplasmático Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article